loader
Please Wait
Applying Filters...

Looking for Pharmaceutical Excipients offered by Gangwal Chemicals? Find Crospovidone based excipient solutions to address drug delivery challenges on PharmaCompass.

Menu
$ API Ref.Price (USD/KG) : 733Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 14Gangwal Chemicals

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

02

arrow
Pharmaconex 2024
Not Confirmed
arrow
Pharmaconex 2024
Not Confirmed

Brand Name : POLYKOVIDONE

Excipient Details : Super disintegrate, solublity enhancer, Suspension stabilizer, Complexing agent, Low peroxide content, Long term stability

Pharmacopoeia Ref :

Technical Specs : Crospovidone (Type-A/B)- USP-NF / Ph. Eur. / BP / IP

Grade : Oral

arrow

Brand : POLYKOVIDONE

Applications : Super disintegrate, solublity enhancer, Suspension stabilizer, Complexing agent, Low peroxide content, Long term stability

Pharmacopoeia Ref : Not Available

Technical Specs : Crospovidone (Type-A/B)- USP-NF / Ph. Eur. / BP / IP

Grade : Oral

arrow
blank

03

arrow
Pharmaconex 2024
Not Confirmed

05

arrow
Pharmaconex 2024
Not Confirmed
arrow
Pharmaconex 2024
Not Confirmed

Brand : F-MELT TYPE M

Applications : F-Melt Type M is used in various dosage forms like orally disintegrating tablets (ODTs), sachets, dispersible tablets, chewable tablets and sublingual formulations.

Pharmacopoeia Ref : Conforms to Japanese Pharmaceutical Excipients. All components meet USP-NF, JP and EP.

Technical Specs : Not Available

Grade : Oral

arrow
blank

06

arrow
Pharmaconex 2024
Not Confirmed
arrow
Pharmaconex 2024
Not Confirmed

Brand : F-MELT TYPE C

Applications : F-Melt Type C is a pharmaceutical excipient used in oral dosage forms like orally disintegrating tablets, sachets, dispersible tablets, chewable tablets and sublingual tablets.

Pharmacopoeia Ref : Conforms to Japanese Pharmaceutical Excipients. All components meet USP-NF, JP, EP. US DMF Type IV filed.

Technical Specs : Not Available

Grade : Oral

arrow
blank

07

arrow
Pharmaconex 2024
Not Confirmed
arrow
Pharmaconex 2024
Not Confirmed
blank